{"nct_id":"NCT00639691","title":"A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy","status":"COMPLETED","status_verified_date":"2016-09","start_date":"2005-01","start_date_type":null,"primary_completion_date":"2011-12","primary_completion_date_type":"ACTUAL","completion_date":"2011-12","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}